101 related articles for article (PubMed ID: 371825)
21. [The leukocyte adherence inhibition test in diagnostics of malignancies (author's transl)].
Sarosiek J; Borejszo I
Przegl Lek; 1981; 38(7):561-5. PubMed ID: 7025111
[No Abstract] [Full Text] [Related]
22. [Clinical uses of the leucocyte adherence inhibition test in patients with laryngeal carcinoma (author's transl)].
Síbl O; Holán V
Cas Lek Cesk; 1979 Jul; 118(27):837-40. PubMed ID: 387249
[No Abstract] [Full Text] [Related]
23. The significance of vaginal hormonal cytology and the leukocyte adherence inhibition test for the detection of malignancy.
Kobilková J; Jandová A; Motlík K; Coupek J; Heyberger K
Acta Cytol; 1983; 27(4):417-20. PubMed ID: 6349199
[TBL] [Abstract][Full Text] [Related]
24. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 2. Preoperative studies and follow-up].
Ludwig HJ; Storch H
Zentralbl Gynakol; 1986; 108(10):607-19. PubMed ID: 3526756
[TBL] [Abstract][Full Text] [Related]
25. [Leukocyte adherence inhibition test (LAI)].
Matsumoto Y
Rinsho Byori; 1981 Apr; (Suppl 45):250-64. PubMed ID: 7026839
[No Abstract] [Full Text] [Related]
26. [Leukocyte adherence inhibition test (LAI): instrumentation, procedure and possibilities for use].
Lehmitz R; Grap H; Schulze H; Ziegler K
Z Med Lab Diagn; 1982 Jan; 23(1):49-54. PubMed ID: 7046275
[No Abstract] [Full Text] [Related]
27. [Mechanisms, kinetics and specificity of the leukocyte adherence inhibition test in breast cancer].
Kharkevich DD; Polevaia EB; Derevnina NA; Sablikova IuA; Savinov AIu
Eksp Onkol; 1985; 7(6):69-73. PubMed ID: 3910405
[TBL] [Abstract][Full Text] [Related]
28. [Studies on the cellular immune response in patients with urinary bladder carcinoma. IV. Leukocyte adherence inhibition tests and leukocyte migration inhibition test (author's transl)].
Nishio S; Horii A; Morikawa Y; Kawakita J; Nishijima T; Maekawa M
Nihon Hinyokika Gakkai Zasshi; 1979 Mar; 70(3):305-16. PubMed ID: 374815
[No Abstract] [Full Text] [Related]
29. [Preliminary experience with the investigation of cellular immunity by the test of inhibition of leucocyte adherence in psoriasis vulgaris (author's transl)].
Vasícková M; Fadrhoncová A; Jandová A; Heyberger K; Coupek J; Sanitrák J
Sb Lek; 1979; 81(11-12):341-3. PubMed ID: 390685
[No Abstract] [Full Text] [Related]
30. [Using cell-mediaed immunity for the diagnosis of toxoplasmosis and trichomoniasis (author's transl)].
Heyberger K; Jandová A; Mejsnarová B; Novotná J; Trnka V
Sb Lek; 1979; 81(11-12):347-8. PubMed ID: 390687
[No Abstract] [Full Text] [Related]
31. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
[TBL] [Abstract][Full Text] [Related]
32. [Attempt at the use of the LAI test as an immunodiagnostic test in precanceroses of the cervix uteri and study on the frequency of nucleic acids].
Novotná J; Cízková J; Heyberger K; Jandová A; Laurová L; Mejsnarová B; Skoda V; Trnka V
Cesk Gynekol; 1979 Jun; 44(5):346-7. PubMed ID: 378433
[No Abstract] [Full Text] [Related]
33. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
Ludwig HJ; Storch H
Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
[TBL] [Abstract][Full Text] [Related]
34. [The effect of 4-acetamidosalicylic acid on the inhibition of leukocyte adherence].
Kobilková J; Jandová A; Kalina C; Motycka K; Potácová M; Jarý J
Sb Lek; 1988 Jan; 90(1):8-13. PubMed ID: 3285451
[No Abstract] [Full Text] [Related]
35. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
Okada Y
Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
[TBL] [Abstract][Full Text] [Related]
36. [Inhibition of the adherence of leukocytes labelled with Cr-51 in colorectal cancer].
Mounielou PM; Clemente F; Estival A; Ribet A
Gastroenterol Clin Biol; 1984 Oct; 8(10):736-41. PubMed ID: 6396147
[TBL] [Abstract][Full Text] [Related]
37. Humoral leukocyte adherence inhibition (H-LAI) before and after surgery in human breast cancer.
Horváth M; Tóth L; Tóth J; Fekete B
Neoplasma; 1985; 32(5):623-7. PubMed ID: 3906415
[TBL] [Abstract][Full Text] [Related]
38. [Possible use of the LAI test in clinical oncology].
Procházka J; Hasek M; Deyl Z; Sobĕslavský C; Sochorová L
Cas Lek Cesk; 1983 Dec; 122(49):1526-30. PubMed ID: 6360376
[No Abstract] [Full Text] [Related]
39. [Some methodical aspects of the leukocyte adherence inhibition test (LAI)].
Teuber S; Storch H
Z Med Lab Diagn; 1986; 27(3):169-73. PubMed ID: 3524045
[No Abstract] [Full Text] [Related]
40. [Methodical standardization for the clinical use of the LAI test].
Jandová A; Heyberger K
Sb Lek; 1980; 82(11-12):382-4. PubMed ID: 7008173
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
